Eugene T Richardson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemorrhagic Fever, Ebola | 15 | 2024 | 424 | 4.510 |
Why?
|
Ebolavirus | 7 | 2023 | 250 | 2.000 |
Why?
|
Disease Outbreaks | 11 | 2024 | 1759 | 1.470 |
Why?
|
Science | 2 | 2020 | 234 | 0.870 |
Why?
|
Africa, Western | 5 | 2024 | 160 | 0.780 |
Why?
|
Civil Disorders | 1 | 2020 | 8 | 0.730 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 404 | 0.700 |
Why?
|
Epidemics | 3 | 2024 | 514 | 0.700 |
Why?
|
Tuberculosis | 3 | 2016 | 2012 | 0.580 |
Why?
|
Public Assistance | 1 | 2017 | 47 | 0.570 |
Why?
|
Virus Diseases | 1 | 2023 | 718 | 0.570 |
Why?
|
Air Pollution | 2 | 2023 | 2380 | 0.530 |
Why?
|
Sierra Leone | 5 | 2021 | 171 | 0.520 |
Why?
|
Carbon Dioxide | 2 | 2016 | 1137 | 0.460 |
Why?
|
Mining | 1 | 2014 | 93 | 0.430 |
Why?
|
Ventilation | 1 | 2014 | 127 | 0.430 |
Why?
|
Loiasis | 1 | 2012 | 2 | 0.400 |
Why?
|
Vaccines | 1 | 2021 | 841 | 0.400 |
Why?
|
Isoniazid | 1 | 2014 | 281 | 0.400 |
Why?
|
Chemoprevention | 1 | 2014 | 327 | 0.380 |
Why?
|
Antibodies, Viral | 2 | 2025 | 3211 | 0.350 |
Why?
|
Eyelid Diseases | 1 | 2012 | 155 | 0.340 |
Why?
|
Cluster Analysis | 1 | 2016 | 2721 | 0.320 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 452 | 0.300 |
Why?
|
Pandemics | 2 | 2020 | 8703 | 0.300 |
Why?
|
Edema | 1 | 2012 | 760 | 0.290 |
Why?
|
Public Health | 2 | 2024 | 2680 | 0.290 |
Why?
|
Biomedical Research | 2 | 2014 | 3458 | 0.280 |
Why?
|
Survivors | 1 | 2017 | 2372 | 0.270 |
Why?
|
Prevalence | 4 | 2024 | 15842 | 0.270 |
Why?
|
Research Personnel | 1 | 2011 | 590 | 0.260 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2016 | 1899 | 0.260 |
Why?
|
Democratic Republic of the Congo | 3 | 2020 | 87 | 0.260 |
Why?
|
Travel | 1 | 2012 | 806 | 0.260 |
Why?
|
HIV Infections | 5 | 2016 | 17533 | 0.250 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7838 | 0.250 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1384 | 0.250 |
Why?
|
Models, Psychological | 2 | 2017 | 824 | 0.240 |
Why?
|
Virus Shedding | 1 | 2025 | 111 | 0.230 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1787 | 0.220 |
Why?
|
Anthropology, Cultural | 1 | 2024 | 103 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.200 |
Why?
|
Tears | 1 | 2024 | 254 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.200 |
Why?
|
Louisiana | 1 | 2021 | 104 | 0.180 |
Why?
|
Thailand | 2 | 2019 | 287 | 0.180 |
Why?
|
Philosophy, Medical | 1 | 2001 | 78 | 0.180 |
Why?
|
Institutionalization | 1 | 2001 | 108 | 0.170 |
Why?
|
Humans | 35 | 2025 | 765968 | 0.170 |
Why?
|
Hospitals, Psychiatric | 1 | 2001 | 317 | 0.160 |
Why?
|
RNA, Viral | 2 | 2025 | 2864 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 166 | 0.160 |
Why?
|
Republic of Korea | 1 | 2021 | 588 | 0.150 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8041 | 0.150 |
Why?
|
Space Perception | 1 | 2001 | 469 | 0.140 |
Why?
|
Water | 1 | 2023 | 1417 | 0.140 |
Why?
|
Climate Change | 1 | 2023 | 509 | 0.140 |
Why?
|
Virus Replication | 1 | 2025 | 2447 | 0.140 |
Why?
|
Semantics | 1 | 2001 | 610 | 0.140 |
Why?
|
Social Justice | 1 | 2021 | 485 | 0.130 |
Why?
|
International Educational Exchange | 1 | 2016 | 54 | 0.130 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7425 | 0.130 |
Why?
|
Human Rights | 2 | 2016 | 312 | 0.130 |
Why?
|
Quality of Life | 1 | 2017 | 13462 | 0.130 |
Why?
|
Panuveitis | 1 | 2015 | 33 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 866 | 0.120 |
Why?
|
Aqueous Humor | 1 | 2015 | 152 | 0.120 |
Why?
|
Crowding | 1 | 2016 | 142 | 0.120 |
Why?
|
Antibodies, Neutralizing | 1 | 2025 | 2010 | 0.120 |
Why?
|
Poverty Areas | 1 | 2016 | 268 | 0.120 |
Why?
|
Transportation | 1 | 2016 | 217 | 0.110 |
Why?
|
Bisexuality | 1 | 2016 | 295 | 0.110 |
Why?
|
Nigeria | 2 | 2016 | 782 | 0.110 |
Why?
|
Violence | 1 | 2019 | 935 | 0.100 |
Why?
|
Diethylcarbamazine | 1 | 2012 | 23 | 0.100 |
Why?
|
Filaricides | 1 | 2012 | 10 | 0.100 |
Why?
|
Food Supply | 1 | 2018 | 544 | 0.100 |
Why?
|
Attitude to Health | 1 | 2001 | 2020 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26318 | 0.090 |
Why?
|
Health Facilities | 1 | 2016 | 577 | 0.090 |
Why?
|
Vaccination | 2 | 2025 | 3426 | 0.090 |
Why?
|
Developed Countries | 1 | 2013 | 452 | 0.090 |
Why?
|
South Africa | 1 | 2016 | 1867 | 0.090 |
Why?
|
Clinical Clerkship | 1 | 2016 | 568 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3807 | 0.080 |
Why?
|
Viral Proteins | 1 | 2016 | 1797 | 0.080 |
Why?
|
Peer Review | 1 | 2011 | 217 | 0.080 |
Why?
|
Program Evaluation | 1 | 2017 | 2499 | 0.080 |
Why?
|
Vision Disorders | 1 | 2015 | 1087 | 0.070 |
Why?
|
Homosexuality, Male | 1 | 2016 | 1342 | 0.070 |
Why?
|
Male | 13 | 2025 | 363698 | 0.070 |
Why?
|
Young Adult | 4 | 2018 | 59889 | 0.070 |
Why?
|
Environmental Monitoring | 1 | 2014 | 1470 | 0.070 |
Why?
|
World Health Organization | 1 | 2013 | 1328 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3564 | 0.070 |
Why?
|
Air Pollution, Indoor | 1 | 2014 | 931 | 0.070 |
Why?
|
Qualitative Research | 1 | 2017 | 3139 | 0.070 |
Why?
|
Adolescent | 4 | 2018 | 88835 | 0.060 |
Why?
|
Schools | 1 | 2014 | 1492 | 0.060 |
Why?
|
Developing Countries | 2 | 2016 | 2911 | 0.060 |
Why?
|
Viral Load | 2 | 2025 | 3386 | 0.050 |
Why?
|
Eye Infections, Viral | 1 | 2024 | 61 | 0.050 |
Why?
|
Students, Medical | 1 | 2016 | 1959 | 0.050 |
Why?
|
Adult | 6 | 2025 | 223044 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3925 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2014 | 1880 | 0.050 |
Why?
|
Africa | 1 | 2024 | 725 | 0.050 |
Why?
|
Child | 2 | 2023 | 80564 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2023 | 136 | 0.050 |
Why?
|
Female | 8 | 2025 | 396112 | 0.050 |
Why?
|
Nursing Methodology Research | 1 | 2001 | 63 | 0.050 |
Why?
|
United States | 3 | 2021 | 72903 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4300 | 0.050 |
Why?
|
Logic | 1 | 2001 | 38 | 0.040 |
Why?
|
Mental Disorders | 1 | 2001 | 6853 | 0.040 |
Why?
|
Middle Aged | 6 | 2025 | 223009 | 0.040 |
Why?
|
Sex Factors | 1 | 2014 | 10603 | 0.040 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4559 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2011 | 1462 | 0.040 |
Why?
|
Incidence | 2 | 2016 | 21480 | 0.040 |
Why?
|
Knowledge | 1 | 2001 | 178 | 0.040 |
Why?
|
Family Characteristics | 1 | 2024 | 1001 | 0.040 |
Why?
|
Emergencies | 1 | 2024 | 1223 | 0.040 |
Why?
|
Time | 1 | 2019 | 550 | 0.040 |
Why?
|
Bolivia | 1 | 2016 | 22 | 0.030 |
Why?
|
Prejudice | 1 | 2001 | 567 | 0.030 |
Why?
|
Gambia | 1 | 2016 | 104 | 0.030 |
Why?
|
Legislation as Topic | 1 | 2016 | 76 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1831 | 0.030 |
Why?
|
Russia | 1 | 2016 | 383 | 0.030 |
Why?
|
Organizations | 1 | 2016 | 172 | 0.030 |
Why?
|
Kenya | 1 | 2016 | 758 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20124 | 0.030 |
Why?
|
Aged | 3 | 2025 | 171117 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2016 | 549 | 0.030 |
Why?
|
Animals | 1 | 2023 | 168764 | 0.020 |
Why?
|
China | 1 | 2016 | 2385 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1432 | 0.020 |
Why?
|
India | 1 | 2016 | 2334 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2739 | 0.020 |
Why?
|
Minority Groups | 1 | 2016 | 1207 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14751 | 0.020 |
Why?
|
Leadership | 1 | 2016 | 1392 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54802 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2016 | 2193 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1938 | 0.010 |
Why?
|
Education, Medical | 1 | 2016 | 1746 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3390 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 24282 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41649 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5370 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74840 | 0.010 |
Why?
|